Page last updated: 2024-11-05

tranexamic acid and Kahler Disease

tranexamic acid has been researched along with Kahler Disease in 3 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cho, SH1
Kim, SW1
Kim, WC1
Chul-Hyun, L1
Go, BS1
de la Puente, P1
Muz, B1
Gilson, RC1
Azab, F1
Luderer, M1
King, J1
Achilefu, S1
Vij, R1
Azab, AK1
Hoshino, Y1
Hatake, K1
Muroi, K1
Tsunoda, S1
Suzuki, T1
Miwa, A1
Sakamoto, S1
Miura, Y1

Other Studies

3 other studies available for tranexamic acid and Kahler Disease

ArticleYear
Hemorrhagic bullous colitis in a patient with multiple myeloma.
    Endoscopy, 2013, Volume: 45 Suppl 2 UCTN

    Topics: Aged; Amyloidosis; Antifibrinolytic Agents; Blister; Bone Density Conservation Agents; Colitis, Isch

2013
3D tissue-engineered bone marrow as a novel model to study pathophysiology and drug resistance in multiple myeloma.
    Biomaterials, 2015, Volume: 73

    Topics: Bone Marrow; Bone Marrow Cells; Cell Line; Cell Line, Tumor; Cell Proliferation; Cytokines; Doxorubi

2015
Bleeding tendency caused by the deposit of amyloid substance in the perivascular region.
    Internal medicine (Tokyo, Japan), 1993, Volume: 32, Issue:11

    Topics: Adrenochrome; Amyloid; Amyloidosis; Blood Vessels; Female; Hematoma; Hemostatics; Humans; Middle Age

1993